Risk assessment and limitations of evaluation studies

被引：0
作者：
Lower, J
机构：
来源：
VIRAL SAFETY AND EVALUATION OF VIRAL CLEARANCE FROM BIOPHARMACEUTICAL PRODUCTS | 1996年 / 88卷
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
[31]   Science-based risk assessment requires careful evaluation of all studies [J].
Fern Wickson ;
Thomas Bøhn ;
Brian Wynne ;
Angelika Hilbeck ;
Silvio Funtowicz .
Nature Biotechnology, 2013, 31 :1077-1078
[32]   RISK ASSESSMENT STUDIES IN RIJNMOND [J].
ROODBOL, HG .
ENVIRONMENT INTERNATIONAL, 1984, 10 (5-6) :441-453
[33]   RISK ASSESSMENT APPROACHES - GENERAL DEFINITIONS, LIMITATIONS, AND RESEARCH NEEDS [J].
WALSH, PJ ;
JONES, TD ;
GRIFFIN, GD ;
DUDNEY, CS ;
CALLE, EE ;
EASTERLY, CE .
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-ENVIRONMENTAL SCIENCE AND ENGINEERING & TOXIC AND HAZARDOUS SUBSTANCE CONTROL, 1982, 17 (04) :541-552
[34]   Limitations of current cardiovascular disease risk assessment strategies in women [J].
Sibley, C ;
Blumenthal, RS ;
Merz, CNB ;
Mosca, L .
JOURNAL OF WOMENS HEALTH, 2006, 15 (01) :54-56
[35]   Proposals to overcome limitations in the EU chemical risk assessment scheme [J].
Trapp, S ;
Schwartz, S .
CHEMOSPHERE, 2000, 41 (07) :965-971
[36]   Limitations in the conventional assessment of the incremental value of predictors of cardiovascular risk [J].
Sniderman, Allan D. ;
Pencina, Michael ;
Thanassoulis, George .
CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (03) :210-214
[37]   Cardiovascular Disease Risk Assessment and Prevention Current Guidelines and Limitations [J].
Alagona, Peter, Jr. ;
Ahmad, Tariq Ali .
MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (04) :711-+
[38]   Unbound bilirubin and risk assessment in the jaundiced newborn: Possibilities and limitations [J].
Hanko, E .
PEDIATRICS, 2006, 117 (02) :526-527
[39]   New tools for coronary risk assessment - What are their advantages and limitations? [J].
Pearson, TA .
CIRCULATION, 2002, 105 (07) :886-892
[40]   Current in vitro methods in nanoparticle risk assessment: Limitations and challenges [J].
Kroll, Alexandra ;
Pillukat, Mike H. ;
Hahn, Daniela ;
Schnekenburger, Juergen .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 72 (02) :370-377
12345